We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

Pfizer, Cellectis Enter Cancer Immunotherapy Collaboration

Collaboration to utilize Cellectis’ proprietary allogeneic CAR-T platform technology to develop immunotherapies against select targets in the field of oncology.

Sterigenics Invests Over $10M for Expansion

Company expand operations in Atlanta, Dallas and Belgium.

KanPro Research Begins Work as 25th KU Startup Company

New startup company designed to tackle protein production.

Retrogenix Opens Office in Cambridge, Massachusetts

Company strengthens its expansion in the United States.

BioLineRx Receives Approval to Commence Phase 1 Trial for BL-8040

Phase 1 trial of BL-8040 expected to begin in Q3 2014.

Evotec Receives Milestone Payment as part of its Discovery Alliance with Boehringer Ingelheim

Company receives milestone payment of € 1.0 m.

Novogen and CanTx Confirm Trx-1 Potency in Ovarian Stem Cell Model

Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15.

StemCells, Inc. Strengthens Senior Executive Team

Company appoints Joel Naor, Naymisha Patel and Mohammad A. El-Kalay and promote Stephen Huhn to the position of vice president.

Can Regenerative Medicine be the Cure for Cancer and Other Deadly Diseases?

Change in regulatory frameworks and standards are essential to expedite approval and release of innovative products.

MRC Technology Sells its MCRs Programme to Pfizer

Small molecules developed in collaboration with Queen Mary University of London.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter